CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Instruments
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PYROGEN TESTING MARKET, BY TEST TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. LAL Test
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Rabbit Pyrogen Test
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: PYROGEN TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmaceutical and Biotechnology Companies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Medical Device Companies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PYROGEN TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product and Service
7.2.3. Market size and forecast, by Test Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product and Service
7.2.5.1.2. Market size and forecast, by Test Type
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product and Service
7.2.5.2.2. Market size and forecast, by Test Type
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product and Service
7.2.5.3.2. Market size and forecast, by Test Type
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product and Service
7.3.3. Market size and forecast, by Test Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product and Service
7.3.5.1.2. Market size and forecast, by Test Type
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product and Service
7.3.5.2.2. Market size and forecast, by Test Type
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product and Service
7.3.5.3.2. Market size and forecast, by Test Type
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product and Service
7.3.5.4.2. Market size and forecast, by Test Type
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product and Service
7.3.5.5.2. Market size and forecast, by Test Type
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product and Service
7.3.5.6.2. Market size and forecast, by Test Type
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product and Service
7.4.3. Market size and forecast, by Test Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product and Service
7.4.5.1.2. Market size and forecast, by Test Type
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product and Service
7.4.5.2.2. Market size and forecast, by Test Type
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product and Service
7.4.5.3.2. Market size and forecast, by Test Type
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product and Service
7.4.5.4.2. Market size and forecast, by Test Type
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product and Service
7.4.5.5.2. Market size and forecast, by Test Type
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product and Service
7.4.5.6.2. Market size and forecast, by Test Type
7.4.5.6.3. Market size and forecast, by End User
7.5. Latin America
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product and Service
7.5.3. Market size and forecast, by Test Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product and Service
7.5.5.1.2. Market size and forecast, by Test Type
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Colombia
7.5.5.2.1. Market size and forecast, by Product and Service
7.5.5.2.2. Market size and forecast, by Test Type
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Argentina
7.5.5.3.1. Market size and forecast, by Product and Service
7.5.5.3.2. Market size and forecast, by Test Type
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest Of La
7.5.5.4.1. Market size and forecast, by Product and Service
7.5.5.4.2. Market size and forecast, by Test Type
7.5.5.4.3. Market size and forecast, by End User
7.6. Middle East and Africa
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by Product and Service
7.6.3. Market size and forecast, by Test Type
7.6.4. Market size and forecast, by End User
7.6.5. Market size and forecast, by country
7.6.5.1. Gcc
7.6.5.1.1. Market size and forecast, by Product and Service
7.6.5.1.2. Market size and forecast, by Test Type
7.6.5.1.3. Market size and forecast, by End User
7.6.5.2. South Africa
7.6.5.2.1. Market size and forecast, by Product and Service
7.6.5.2.2. Market size and forecast, by Test Type
7.6.5.2.3. Market size and forecast, by End User
7.6.5.3. North Africa
7.6.5.3.1. Market size and forecast, by Product and Service
7.6.5.3.2. Market size and forecast, by Test Type
7.6.5.3.3. Market size and forecast, by End User
7.6.5.4. Rest Of Mea
7.6.5.4.1. Market size and forecast, by Product and Service
7.6.5.4.2. Market size and forecast, by Test Type
7.6.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Lonza Group AG
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Thermo Fisher Scientific Inc.
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Fujifilm Holdings Corporation
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. GenScript
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. SEIKAGAKU CORPORATION
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Charles River Laboratories
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. STERIS plc
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Wuxi AppTec
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Eurofins Scientific SE
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Merck KGaA
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
| ※参考情報 パイロジェン検査は、医薬品や医療機器の安全性を評価するための重要な試験です。パイロジェンとは、体温を上昇させる物質を指し、特に細菌由来の内因性パイロジェンであるエンドトキシンが多く関与しています。エンドトキシンは、グラム陰性菌の細胞壁に存在し、これが体内に入ると免疫反応を引き起こし、発熱やショックなどを引き起こす可能性があります。そのため、パイロジェン検査は、医薬品や医療機器が人間に投与されたときに、パイロジェンが原因で生じるリスクを最小限に抑えることを目的としています。 パイロジェン検査は主にいくつかの方法に分かれます。最も一般的な方法は、ラビットパイロジェン検査です。この方法は、ウサギに薬剤や医療機器を投与し、その後に体温の変化を観察します。ウサギの体温が特定の基準以上に上昇した場合、その試料にはパイロジェンが含まれていると見なされます。また、バイオロジカル検査としても知られています。ウサギを使用するため、この方法は時間とコストがかかるといったデメリットがあります。 次に、リムルス血液試薬を用いたエンドトキシン検査があります。この方法は、特にリムルスガニという海洋生物の血液を利用します。リムルスガニの血液にはエンドトキシンに反応する成分が含まれており、それを用いることで迅速にエンドトキシンの検出が可能です。この方法は、非常に高感度であり、エンドトキシンの量を正確に測定できるため、広く利用されています。また、時間的コストも低く、動物を使用しないため倫理的な側面でも評価されています。 さらに、最近では分子生物学的技術を活用した革新的な検査法も開発されています。たとえば、PCR（ポリメラーゼ連鎖反応）技術を利用して、エンドトキシンの遺伝子を特定し検出する方法や、高速液体クロマトグラフィー（HPLC）によって化学的な成分を解析する方法もあります。これにより、より迅速で高精度な検査が可能となります。これらの新しい技術は、従来の方法と比較して効率的で、特定の病原体やエンドトキシンの種類を明確にすることができるため、医学研究や産業界でも注目されています。 パイロジェン検査の用途は多岐にわたります。主に、注射剤、輸液、ワクチン、医療機器など、患者に直接投与される製品の安全性を確認するために用いられます。特に、ワクチンや生物学的製剤では、パイロジェンの存在が患者に重大な影響を及ぼすため、厳密な検査が求められます。また、血液製剤においても、パイロジェンの検出が不可欠であり、患者の安全を守るための基本的な措置です。 パイロジェン検査が重要な理由は、患者の健康に直接かかわるからです。エンドトキシンの影響がある製品を使用した場合、患者は重篤な副作用を受ける可能性があります。そのため、多くの国で規制が設けられ、製薬企業や医療機器メーカーは、法的な基準に従ってパイロジェン検査を実施し、コンプライアンスを守ることが求められます。このような基準に従っていない場合、製品は承認されず、市場から排除される可能性もあります。 パイロジェン検査の関連技術や手法は、今後さらなる進展が望まれています。特に、ナノテクノロジーや人工知能（AI）などの最先端技術を取り入れることで、より迅速で高精度な検査が実現できると期待されます。これにより、医療の進歩とともに患者の安全性が向上し、医療分野における新たなスタンダードとなるでしょう。 パイロジェン検査は、現代の医療において不可欠な技術の一つであり、その重要性は今後ますます増していくと考えられます。これにより、私たちの健康が守られ、安全な医療環境が構築されていくことを期待しています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
